iShares U.S. Pharmaceuticals ETF Rating $70.72 -0.32 (-0.45%) Closing price 04:10 PM EasternExtended Trading$70.74 +0.03 (+0.04%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.64Holdings in IHE have an aggregate rating of Moderate Buy based on 253 analyst ratings issued in the past year covering 25 companies (96.0% of the portfolio).IHE Aggregate Price Target$70.72High Prediction$70.72Average Prediction$70.72Low Prediction$70.72Holdings in IHE have an aggregate price target of $70.72 and a range of $70.72 to $70.72 covering 25 companies (96.0% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings24.37%JNJJohnson & Johnson$175.50-0.7%4.8738 of 5 stars2.65$176.29 0.4%20Positive NewsOptions Volume21.32%LLYEli Lilly and Company$732.25-0.3%4.9985 of 5 stars2.67$950.17 29.8%24Trending NewsAnalyst Upgrade4.93%RPRXRoyalty Pharma$35.62-1.2%4.9807 of 5 stars3.33$48.00 34.8%3Positive News4.46%MRKMerck & Co., Inc.$83.24-1.0%4.997 of 5 stars2.35$107.44 29.1%20Positive News4.44%VTRSViatris$10.41-0.1%1.9593 of 5 stars1.80$10.40 -0.1%54.34%PFEPfizer$24.60-1.9%4.8797 of 5 stars2.39$28.12 14.3%18Trending News4.01%ZTSZoetis$154.79-0.4%4.9243 of 5 stars2.50$202.43 30.8%8Trending NewsAnalyst Revision3.99%BMYBristol Myers Squibb$46.89-1.6%4.7425 of 5 stars2.24$56.38 20.2%21Positive News3.52%JAZZJazz Pharmaceuticals$126.13+1.4%4.7535 of 5 stars2.87$178.21 41.3%15Analyst Forecast3.38%ELANElanco Animal Health$18.47-0.1%2.8656 of 5 stars2.78$17.33 -6.2%9High Trading Volume3.22%CORTCorcept Therapeutics$69.58-0.2%4.7623 of 5 stars3.00$134.50 93.3%5Positive News2.10%AXSMAxsome Therapeutics$121.75-0.1%4.7772 of 5 stars3.07$178.00 46.2%15News CoveragePositive NewsInsider Trade1.81%PRGOPerrigo$23.78-0.5%4.9777 of 5 stars2.40$33.00 38.8%5Positive News1.80%PBHPrestige Consumer Healthcare$67.37+0.6%4.6906 of 5 stars2.50$93.33 38.5%6Positive News1.26%LGNDLigand Pharmaceuticals$159.96+0.5%4.0888 of 5 stars3.00$165.17 3.3%6Positive NewsAnalyst Forecast1.25%OGNOrganon & Co.$9.18-0.3%4.7966 of 5 stars2.50$18.00 96.2%6Positive News0.98%SUPNSupernus Pharmaceuticals$45.37+0.7%2.0952 of 5 stars2.50$41.00 -9.6%4Insider Trade0.77%TARSTarsus Pharmaceuticals$58.16+0.6%1.8228 of 5 stars3.00$66.67 14.6%7Positive News0.76%OCULOcular Therapeutix$12.52+1.6%4.1557 of 5 stars3.00$17.20 37.4%5Positive NewsInsider Trade0.65%HRMYHarmony Biosciences$37.97-0.2%4.6491 of 5 stars3.00$51.00 34.3%10Positive News0.58%AMRXAmneal Pharmaceuticals$9.55+2.0%3.268 of 5 stars3.00$11.60 21.5%5Positive NewsInsider Trade0.54%ANIPANI Pharmaceuticals$92.53+0.7%3.2542 of 5 stars3.10$84.75 -8.4%10Insider Trade0.51%INVAInnoviva$20.03+1.0%4.4881 of 5 stars3.00$42.75 113.4%4Positive News0.51%WVEWAVE Life Sciences$9.93-1.5%4.7744 of 5 stars2.93$20.27 104.1%15Insider Trade0.50%PCRXPacira BioSciences$26.85+2.8%3.3504 of 5 stars2.71$30.83 14.8%7News CoveragePositive News This page (NYSEARCA:IHE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access